. 2017 Oct 30;9(3):529–535. doi: 10.1111/jdi.12731

Table 2.

Results of univariate regression analysis of hepatic and muscle insulin sensitivity using data of 29 non‐obese type 2 diabetes patients

	% Reduction of EGP		Rd
	r	P‐value	r	P‐value
Age	0.33	0.08	−0.002	0.99
Duration	0.06	0.75	0.003	0.99
BMI	−0.29	0.13	−0.36	0.06
Total body fat content	−0.10	0.60	−0.44^a	<0.05^a
Systolic blood pressure	0.08	0.68	0.16	0.40
Diastolic blood pressure	−0.02	0.94	0.03	0.90
Waist	−0.16	0.42	−0.01	0.62
Alcohol intake	−0.07	0.74	0.06	0.77
Aspartate aminotransferase	−0.31	0.10	−0.30	0.12
Alanine aminotransferase	−0.58^a	<0.01^a	−0.67^a	<0.01^a
γ‐Glutamyl transferase	−0.41^a	<0.05^a	−0.33	0.09
Platelet	−0.04	0.84	−0.02	0.93
Type 4 collagen	−0.19	0.33	0.20	0.29
Ferritin	−0.43^a	<0.05^a	−0.34	0.07
Fasting plasma glucose	−0.37	0.05	−0.36	0.06
Fasting serum insulin	−0.22	0.25	−0.64^a	<0.01^a
HbA1c	−0.21	0.28	−0.35	0.06
HOMA‐IR	−0.40^a	<0.05^a	−0.67^a	<0.01^a
LDL cholesterol	0.12	0.53	−0.18	0.35
HDL cholesterol	−0.01	0.94	0.25	0.19
Triglyceride	−0.30	0.11	−0.27	0.15
Basal EGP	0.02	0.91	0.24	0.22
Free fatty acid	0.16	0.42	−0.20	0.31
HMW‐adiponectin	0.26	0.18	0.30	0.12
CRP	−0.33	0.08	−0.08	0.68
Visceral fat area	−0.13	0.51	−0.23	0.23
Subcutaneous fat area	−0.08	0.68	−0.16	0.41
Intrahepatic lipid	−0.02	0.92	−0.32	0.09
IMCL in tibialis anterior muscle	0.01	0.95	0.11	0.60

Statistically significant.

BMI, body mass index; CRP, C‐reactive protein; EGP, endogenous glucose production; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; HOMA‐IR, homeostasis model assessment of insulin resistance; HMW, high molecular weight; IMCL, intramyocellular lipid; Rd, rate of glucose disposal.